SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001171843-11-002492
Filing Date
2011-08-12
Accepted
2011-08-12 08:00:46
Documents
10
Period of Report
2011-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q f10q_081211.htm 10-Q 339958
2 EXHIBIT 31.1 exh_312.htm EX-31 12108
3 EXHIBIT 31.2 exh_311.htm EX-31 11873
4 EXHIBIT 32.1 exh_32.htm EX-32 6665
  Complete submission text file 0001171843-11-002492.txt   1204687

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT caps-20110630.xml EX-101.INS 67206
6 XBRL TAXONOMY EXTENSION SCHEMA caps-20110630.xsd EX-101.SCH 11696
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE caps-20110630_cal.xml EX-101.CAL 21621
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE caps-20110630_def.xml EX-101.DEF 46977
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE caps-20110630_lab.xml EX-101.LAB 107054
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE caps-20110630_pre.xml EX-101.PRE 61371
Mailing Address 1275 WEST WASHINGTON STREET SUITE 101 TEMPE AZ 85281
Business Address 1275 WEST WASHINGTON STREET SUITE 101 TEMPE AZ 85281 6022865520
Capstone Therapeutics Corp. (Filer) CIK: 0000887151 (see all company filings)

IRS No.: 860585310 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33560 | Film No.: 111029179
SIC: 2834 Pharmaceutical Preparations